Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies

被引:0
|
作者
Cohen, JD [1 ]
Cunin, P [1 ]
Farrenq, V [1 ]
Oniankitan, O [1 ]
Carton, L [1 ]
Chevalier, X [1 ]
Claudepierre, P [1 ]
机构
[1] Henri Mondor Teaching Hosp, APHP, Dept Rheumatol, Clin Res Unit, Creteil, France
关键词
ankylosing spondylitis; spondyloarthropathy; patient assessment; Bath Ankylosing Spondylitis Disease Activity Index; cutoff;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To estimate the best Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) cutoff based on patients' perceptions of symptom relief collected in a large population of patients with spondyloarthropathies (SpA), in comparison to the BASDAI cutoff determined by experts. Methods. A survey of patient perceptions about current disease control was conducted among the members of Spondylis, one of the main not-for-profit SpA patient organizations in France. BASDAI was among data collected by the questionnaire. To estimate the best BASDAI cutoff for discriminating between poor and well perceived controlled groups, we plotted the receiver operating characteristic (ROC) curve. We also determined the cutoff separately in male and female patients. Results. Of the 1000 mailed questionnaires, 485 were returned without any missing data regarding perceived disease control and the BASDAI. Of these patients, 55.3% perceived inadequate control of their disease. The mean BASDAI in the overall population was 43.5 +/- 22.9, 30.4 +/- 19.9 in the well controlled group and 54 +/- 19.4 in the poorly controlled group (p < 0.001). The best BASDAI cutoff for discriminating between patients in the 2 groups was 39 (sensitivity 74.6% and specificity 72.4%). According to gender, the best cutoff was 44 for women and 36 for men. Conclusion. The best BASDAI cutoff of 39 based on patients' perceptions was very similar to that selected by international experts, i.e., 40. Gender affected the cutoff for perceived symptom relief in our study. These results need to be confirmed by further studies collecting the opinions of both patients and physicians.
引用
收藏
页码:79 / 81
页数:3
相关论文
共 50 条
  • [1] Bath Ankylosing Spondylitis Disease Activity Index is Associated With the Quality of Sleep in Ankylosing Spondylitis Patients
    Song, Byung Wook
    Jeong, Hye-Jin
    Kim, Bo Young
    Cho, Yong Won
    Son, Chang-Nam
    Kim, Sung-Soo
    Kim, Sang-Hyon
    JOURNAL OF RHEUMATIC DISEASES, 2021, 28 (03): : 143 - 149
  • [2] Evaluation of the Iranian versions of the bath ankylosing spondylitis disease activity index (BASDAI), the bath ankylosing spondylitis functional index (BASFI) and the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
    Bidad, Katayoon
    Fallahi, Sasan
    Mahmoudi, Mahdi
    Jamshidi, Ahmadreza
    Farhadi, Elham
    Meysamie, Alipasha
    Nicknam, Mohammad Hossein
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (11) : 3613 - 3618
  • [3] Evaluation of the Iranian versions of the bath ankylosing spondylitis disease activity index (BASDAI), the bath ankylosing spondylitis functional index (BASFI) and the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
    Katayoon Bidad
    Sasan Fallahi
    Mahdi Mahmoudi
    Ahmadreza Jamshidi
    Elham Farhadi
    Alipasha Meysamie
    Mohammad Hossein Nicknam
    Rheumatology International, 2012, 32 : 3613 - 3618
  • [4] Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI)
    Fallahi, Sasan
    Jamshidi, Ahmad Reza
    Gharibdoost, Farhad
    Mahmoudi, Mahdi
    Paragomi, Pedram
    Nicknam, Mohammad Hossein
    Farhadi, Elham
    Qorbani, Mostafa
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2012, 3 (04) : 508 - 513
  • [5] The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the bath ankylosing spondylitis disease activity index
    Heuft-Dorenbosch, L
    Van Tubergen, A
    Spoorenberg, A
    Landewé, R
    Dougados, M
    Mielants, H
    Van der Tempel, H
    Van der Heijde, D
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 154 - 159
  • [6] Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?
    Calin, A
    Nakache, JP
    Gueguen, A
    Zeidler, H
    Mielants, H
    Dougados, M
    RHEUMATOLOGY, 1999, 38 (09) : 878 - 882
  • [7] Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
    Rostom, Samira
    Benbouaaza, Karima
    Amine, Bouchra
    Bahiri, Rachid
    Ibn Yacoub, Yousra
    Alla, Sanae Ali Ou
    Abouqal, Redouane
    Hajjaj-Hassouni, Najia
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 781 - 788
  • [8] Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
    Samira Rostom
    Karima Benbouaaza
    Bouchra Amine
    Rachid Bahiri
    Yousra Ibn Yacoub
    Sanae Ali Ou Alla
    Redouane Abouqal
    Najia Hajjaj-Hassouni
    Clinical Rheumatology, 2010, 29 : 781 - 788
  • [9] Evaluation of a French version of the bath ankylosing spondylitis disease activity index in patients with spondyloarthropathy
    Claudepierre, P
    Sibilia, T
    Goupille, P
    Flipo, RM
    Wendling, D
    Eulry, F
    Clerc, D
    Berthelot, JM
    Vergne, P
    RoudotThoraval, F
    LargetPiet, B
    Chevalier, X
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (10) : 1954 - 1958
  • [10] Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) for use in Ukraine
    Oleg Nadashkevich
    Oleksiy Masyk
    Clinical Rheumatology, 2011, 30 : 1305 - 1310